COARELLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 982
EU - Europa 394
AS - Asia 162
SA - Sud America 17
AF - Africa 7
Totale 1.562
Nazione #
US - Stati Uniti d'America 982
IT - Italia 191
SG - Singapore 67
SE - Svezia 58
IN - India 42
CN - Cina 41
DE - Germania 26
FI - Finlandia 26
AT - Austria 22
RU - Federazione Russa 22
BR - Brasile 10
UA - Ucraina 10
FR - Francia 7
GB - Regno Unito 6
AR - Argentina 5
BG - Bulgaria 5
IE - Irlanda 4
RO - Romania 4
TG - Togo 4
ES - Italia 3
ID - Indonesia 3
IR - Iran 3
BE - Belgio 2
CO - Colombia 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
IQ - Iraq 2
JP - Giappone 2
NL - Olanda 2
PT - Portogallo 2
EE - Estonia 1
LT - Lituania 1
SC - Seychelles 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 1.562
Città #
Ashburn 144
Fairfield 139
Chandler 104
Cambridge 65
Rome 64
Woodbridge 59
Seattle 57
Houston 55
Singapore 48
Wilmington 47
Santa Clara 34
Princeton 22
Fasano 21
Plano 21
Ann Arbor 20
Beijing 20
Vienna 19
Varedo 17
Dearborn 16
Lawrence 14
Boston 13
San Mateo 9
San Paolo di Civitate 9
Millbury 8
Norwalk 8
San Diego 8
Helsinki 7
Milan 7
Moscow 7
Andover 6
Falkenstein 6
Bari 5
Champs-sur-marne 5
Federal 5
Sofia 5
Grafing 4
Lomé 4
Albano Laziale 3
Barcelona 3
Boardman 3
Bühl 3
Dublin 3
Hefei 3
Jakarta 3
Martellago 3
Phoenix 3
Sant'Elena 3
Andria 2
Baotou 2
Bogotá 2
Brno 2
Brussels 2
Campi Bisenzio 2
Canary Wharf 2
Catania 2
Des Moines 2
Ercolano 2
Fārsān 2
Hong Kong 2
Ilvesheim 2
Jacksonville 2
Karbala 2
Mannheim 2
Monte Roberto 2
Nanjing 2
Nürnberg 2
Palhaca 2
Pisa 2
Santo André 2
Sassuolo 2
Shanghai 2
Southend 2
Abaeté 1
Bolzano Vicentino 1
Bremen 1
Changsha 1
Chicago 1
Dallas 1
Feltre 1
Florence 1
Guangzhou 1
Guidonia Montecelio 1
Hebei 1
Heidelberg 1
Itajaí 1
Jiaxing 1
Jinan 1
Mahdia 1
Mountain View 1
Muizenberg 1
Nova Serrana 1
Nuremberg 1
Padova 1
Passo Fundo 1
Pavia 1
Provo 1
Pune 1
Redmond 1
Redwood City 1
Romola 1
Totale 1.210
Nome #
Riluzole in patients with hereditary cerebellar ataxia. a randomised, double-blind, placebo-controlled trial 112
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS 110
La neurologia della Sapienza 96
Characterization of Epstein–Barr virus genotypes in multiple sclerosis through next generation sequencing approaches 86
Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases 85
Evidence for detrimental cross interactions between reactive oxygen and nitrogen species in Leber's hereditary optic neuropathy cells 83
Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia 82
Multiple sclerosis etiology: beyond genes and environment 79
Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins 77
Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood 77
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS. 76
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS. 74
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab 73
Serum elements and oxidative status in clinically isolated syndromes Imbalance and predictivity 73
Riluzole in patients with hereditary cerebellar ataxia. Authors' reply 67
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis. 58
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of an Italian cohort of 462 cases. 56
The response to Toll-like receptor stimulation is impaired in plasmacytoid dendritic cells of multiple sclerosis patients undergoing interferon-b therapy 52
Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias 46
Characterization of Epstein-Barr virus genotypes in multiple sclerosis 45
Effects of the Bacillus Calmette-Guérin (BCG) Vaccine in the Demyelinating Disease of the Central Nervous SystemThe Value of BCG and TNF in Autoimmunity 43
Transciptome of B lymphocytes in multiple sclerosis 40
Sclerosi Multipla 33
Effects of bacille calmette-gu{\'e}rin after the first demyelinating event in the CNS: Response 9
Totale 1.632
Categoria #
all - tutte 5.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202082 0 0 0 0 0 0 0 0 36 25 17 4
2020/2021108 14 8 25 5 1 2 4 4 14 24 3 4
2021/2022267 0 11 30 10 54 6 4 27 8 21 49 47
2022/2023285 41 54 17 34 35 39 2 18 30 2 11 2
2023/2024226 3 15 3 22 14 27 11 68 1 14 28 20
2024/2025202 24 19 11 14 23 56 30 18 7 0 0 0
Totale 1.632